Results 171 to 180 of about 320,703 (320)

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks [PDF]

, 2018
Dong, Qunming, Hendin, Barry, Huang, Deren, Jhaveri, Mehul, Jones, Daniel L, Livingston, Terrie, Naismith, Robert T, Watson, Crystal, Wray, Sibyl E   +8 more
core   +1 more source

Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B. [PDF]

World J Gastroenterol
Fu YC, Li J, Wang JY, Zhang YW, Yan F, Chen J, Du Q, Yang C, Liang J, Ye Q, Xiang HL.   +10 more
europepmc   +1 more source

Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B. [PDF]

Front Immunol, 2023
Huang L, Zhang H, Kang X, Chen Z, Wang L, Zeng Y.   +5 more
europepmc   +1 more source

Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection. [PDF]

Drug Des Devel Ther
Zhang Y, Li Y, Lian JQ, Kang W.
europepmc   +1 more source

The role of genomic and antigenomic HCV‐RNA strands as predictive factors of response to pegylated interferon plus ribavirin therapy [PDF]

, 2007
Juan Manuel López‐Alcorocho, Elena Rodríguez‐Iñigo, Inmaculada Castillo, María Eugenia Castellanos, Matias Pardo, Javier Bartolomé, Jorge Quiroga, V. Carreño   +7 more
openalex   +1 more source

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High‐Risk Melanoma

Pediatric Blood & Cancer, 2016
F. Navid, C. Herzog, J. Sandoval, Vinay M. Daryani, C. Stewart, J. Gattuso, B. Mandrell, S. Phipps, W. Chemaitilly, A. Sykes, A. Davidoff, B. Shulkin, A. Bahrami, W. Furman, S. Mao, Jianrong Wu, D. Schiff, B. Rao, A. Pappo   +18 more
semanticscholar   +1 more source

Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study. [PDF]

Front Cell Infect Microbiol, 2023
Wen C, Wang Y, Tian H, Lei Y, Wang Z, Cai D, Zhou Z, Shi X.   +7 more
europepmc   +1 more source

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

Hepatology, 2015
W. Brouwer, Q. Xie, M. Sonneveld, Ning-ping Zhang, Qin Zhang, F. Tabak, A. Streinu-Cercel, Ji‐yao Wang, R. Idilman, H. Reesink, M. Diculescu, K. Simon, M. Voiculescu, M. Akdoğan, W. Mazur, J. Reijnders, Elke Verhey, B. Hansen, H. Janssen   +18 more
semanticscholar   +1 more source

470 DOES HEPATIC STEATOSIS OR OBESITY INFLUENCE THE EFFICACY OF PEGYLATED INTERFERONS DIFFERENTLY?

, 2011
Savvoula Savvidou, John Goulis, Dimitrios Chrysagis, George Papatheodoridis, Spilios Manolakopoulos, C. Triantos, Evangelos Akriviadis   +6 more
openalex   +1 more source

Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection. [PDF]

J Viral Hepat
Hardtke S, Yurdaydin C, Caruntu FA, Curescu MG, Yalcin K, Akarca US, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Port K, Manns MP, Cornberg M, Kahlhöfer J, Wedemeyer H.   +15 more
europepmc   +1 more source